James Investment Research’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,517	Closed	-$322K	–	645
2022 Q4	$322K	Sell	43,517 -565	-1%	-$5.5K	0.05%	215
2022 Q3	$436K	Hold	44,082	–	–	0.06%	186
2022 Q2	$480K	Hold	44,082	–	–	0.06%	183
2022 Q1	$499K	Hold	44,082	–	–	0.05%	201
2021 Q4	$692K	Hold	44,082	–	–	0.06%	183
2021 Q3	$756K	Hold	44,082	–	–	0.07%	171
2021 Q2	$948K	Hold	44,082	–	–	0.08%	158
2021 Q1	$662K	Buy	44,082 +24,372	+124%	+$395K	0.06%	180
2020 Q4	$259K	Buy	19,710 +25	+0.1%	+$301	0.02%	246
2020 Q3	$190K	Hold	19,685	–	–	0.02%	257
2020 Q2	$225K	Buy	19,685 +1,505	+8%	+$17K	0.02%	240
2020 Q1	$188K	Buy	+18,180	New	+$225K	0.02%	234
2019 Q1	–	Sell	-41,400	Closed	-$1.08M	–	914
2018 Q4	$1.08M	Buy	+41,400	New	+$973K	0.07%	290